l 694247 has been researched along with mdl 100907 in 1 studies
| Studies (l 694247) | Trials (l 694247) | Recent Studies (post-2010) (l 694247) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
|---|---|---|---|---|---|
| 32 | 0 | 8 | 1,241 | 65 | 539 |
| Protein | Taxonomy | l 694247 (IC50) | mdl 100907 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, M; García-Pedraza, JA; Martín, ML; Morán, A; Rodríguez-Barbero, A | 1 |
1 other study(ies) available for l 694247 and mdl 100907
| Article | Year |
|---|---|
5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
Topics: Animals; Dose-Response Relationship, Drug; Epoprostenol; KATP Channels; Kidney; Male; Nitric Oxide; Oxadiazoles; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Tryptamines; Vasodilator Agents | 2016 |